Published in Front Mol Neurosci on February 03, 2017
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science (2012) 48.17
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26
RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell (2000) 20.32
Evolution and functions of long noncoding RNAs. Cell (2009) 17.54
RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol (2013) 15.51
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol (2004) 15.15
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol (2013) 14.28
Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50
MicroRNAs regulate brain morphogenesis in zebrafish. Science (2005) 11.16
Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (2014) 10.43
A brain-specific microRNA regulates dendritic spine development. Nature (2006) 10.18
CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu Rev Genet (2011) 9.88
A microRNA array reveals extensive regulation of microRNAs during brain development. RNA (2003) 9.76
CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell (2013) 9.55
Long noncoding RNAs: functional surprises from the RNA world. Genes Dev (2009) 9.14
Genome-wide association study identifies five new schizophrenia loci. Nat Genet (2011) 9.07
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell (2015) 7.80
A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A (2005) 6.61
Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet (2013) 5.48
Genomic analysis of mouse retinal development. PLoS Biol (2004) 4.66
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science (2015) 4.18
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol (2015) 3.56
Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry (1999) 3.07
Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science (2015) 2.97
In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science (2015) 2.85
Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res (2013) 2.73
Therapeutic genome editing: prospects and challenges. Nat Med (2015) 2.42
Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet (2006) 2.41
The schizophrenia risk gene product miR-137 alters presynaptic plasticity. Nat Neurosci (2015) 2.37
Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus (2010) 2.30
The mRNA-like noncoding RNA Gomafu constitutes a novel nuclear domain in a subset of neurons. J Cell Sci (2007) 2.23
TALEN-based gene correction for epidermolysis bullosa. Mol Ther (2013) 1.84
Schizophrenia. Lancet (2016) 1.83
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature (2016) 1.80
Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci (2016) 1.58
The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol (2000) 1.54
microRNA regulation of synaptic plasticity. Neuromolecular Med (2009) 1.49
Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection. Proc Natl Acad Sci U S A (2014) 1.49
DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs. BMC Genomics (2015) 1.45
The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Mol Psychiatry (2013) 1.44
Anemia: progress in molecular mechanisms and therapies. Nat Med (2015) 1.41
The long noncoding RNA RNCR2 directs mouse retinal cell specification. BMC Dev Biol (2010) 1.39
Muscle physiology. A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle. Science (2016) 1.35
Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology (2013) 1.34
Generation of an ICF syndrome model by efficient genome editing of human induced pluripotent stem cells using the CRISPR system. Int J Mol Sci (2013) 1.34
Experience-dependent expression of miR-132 regulates ocular dominance plasticity. Nat Neurosci (2011) 1.32
MicroRNA dysregulation in schizophrenia. Neurobiol Dis (2011) 1.28
Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines. Nucleic Acids Res (2014) 1.26
The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders. Front Psychiatry (2012) 1.22
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia. Mol Psychiatry (2013) 1.16
Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9. RNA Biol (2014) 1.16
Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells. J Biol Chem (2013) 1.13
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol (2016) 1.11
Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells. Stem Cell Reports (2014) 1.11
MIR137 gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese. Schizophr Res (2013) 1.09
Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation. Stem Cells (2015) 1.07
MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets. Mol Psychiatry (2014) 0.94
CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo. Sci Rep (2016) 0.90
Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression. Am J Psychiatry (2015) 0.89
Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients. Mol Ther Nucleic Acids (2014) 0.87
Prenatal genetic testing with chromosomal microarray analysis identifies major risk variants for schizophrenia and other later-onset disorders. Am J Psychiatry (2013) 0.86
Meta gene set enrichment analyses link miR-137-regulated pathways with schizophrenia risk. Front Genet (2015) 0.84
MicroRNA-137 Controls AMPA-Receptor-Mediated Transmission and mGluR-Dependent LTD. Cell Rep (2015) 0.84
LncRNA MIAT: Myocardial infarction associated and more. Gene (2015) 0.84
Association of a miRNA-137 polymorphism with schizophrenia in a Southern Chinese Han population. Biomed Res Int (2014) 0.82
The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals. Am J Med Genet B Neuropsychiatr Genet (2014) 0.82
The impact of genome wide supported microRNA-137 (MIR137) risk variants on frontal and striatal white matter integrity, neurocognitive functioning, and negative symptoms in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2015) 0.81
microRNAs as novel biomarkers of schizophrenia (Review). Exp Ther Med (2014) 0.81
Association of microRNA137 gene polymorphisms with age at onset and positive symptoms of schizophrenia in a Han Chinese population. Int J Psychiatry Med (2014) 0.81
Human Genome Editing and Ethical Considerations. Sci Eng Ethics (2015) 0.81
Genetic variants in long non-coding RNA MIAT contribute to risk of paranoid schizophrenia in a Chinese Han population. Schizophr Res (2015) 0.80
Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia. Transl Psychiatry (2016) 0.78
Gene-editing research in human embryos gains momentum. Nature (2016) 0.78
The Multifarious Hippocampal Functions of MicroRNA-137. Neuroscientist (2015) 0.77
MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia. J Psychiatry Neurosci (2014) 0.77
Associating schizophrenia, long non-coding RNAs and neurostructural dynamics. Front Mol Neurosci (2015) 0.77
Developmental suppression of schizophrenia-associated miR-137 alters sensorimotor function in zebrafish. Transl Psychiatry (2016) 0.76